SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-433915
Filing Date
2013-11-08
Accepted
2013-11-08 06:22:21
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d606497d10q.htm 10-Q 173581
2 EX-31.1 d606497dex311.htm EX-31.1 8922
3 EX-31.2 d606497dex312.htm EX-31.2 8920
4 EX-32.1 d606497dex321.htm EX-32.1 4891
  Complete submission text file 0001193125-13-433915.txt   1942254

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20130930.xml EX-101.INS 149794
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20130930.xsd EX-101.SCH 24195
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20130930_cal.xml EX-101.CAL 27771
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20130930_def.xml EX-101.DEF 148016
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20130930_lab.xml EX-101.LAB 231070
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20130930_pre.xml EX-101.PRE 171236
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 131202474
SIC: 2834 Pharmaceutical Preparations